Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Carcinoma, Non-Small-Cell Lung 42Small Cell Lung Carcinoma 19Breast Neoplasms 16Sarcoma 12Lung Neoplasms 9Esophageal Squamous Cell Carcinoma 7Carcinoma, Hepatocellular 7Thyroid Neoplasms 6Stomach Neoplasms 6Nasopharyngeal Carcinoma 6Esophageal Neoplasms 6Ovarian Neoplasms 5NSCLC 5Carcinoma 5Triple Negative Breast Neoplasms 4Pheochromocytoma 4Pancreatic Neoplasms 4Neoplasm Metastasis 4Colorectal Neoplasms 4Carcinoma, Ovarian Epithelial 4Recurrence 3Paraganglioma 3Neoplasms 3Glioma 3Cholangiocarcinoma 3Brain Neoplasms 3Biliary Tract Neoplasms 3Uterine Cervical Neoplasms 2Urogenital Neoplasms 2Platinum-resistant Ovarian Cancer 2

Interventions

Cyclophosphamide 16Temozolomide 13Vincristine 10Irinotecan 8Melphalan 7Doxorubicin 7Topotecan 6Granulocyte Colony-Stimulating Factor 6Busulfan 6fludarabine 5cabozantinib 5Etoposide 5Drug Therapy 5liposomal doxorubicin 4Sirolimus 4Ifosfamide 4Filgrastim 4regorafenib 3pegfilgrastim 3irinotecan sucrosofate 3fludarabine phosphate 3Zoledronic Acid 3Radiotherapy 3Nivolumab 3Magnetic Resonance Spectroscopy 3Gemcitabine 3Cisplatin 3Bone Marrow Transplantation 3Albumin-Bound Paclitaxel 3pegylated granulocyte colony-stimulating factor 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Sarcoma, Ewing × anlotinib × Clear all
NCT03416517 2019-02-15

Anlotinib and Irinotecan for Ewing Sarcoma

Peking University People's Hospital

Phase 1/2 Unknown
47 enrolled
Sarcoma

Neoplasm Metastasis, Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡